These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6799967)

  • 1. Haloperidol-induced hyperactivity in neonatal rats: effect of lithium and stimulants.
    Schechter MD; Concannon JT
    Pharmacol Biochem Behav; 1982 Jan; 16(1):1-5. PubMed ID: 6799967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment.
    Luthman J; Fredriksson A; Lewander T; Jonsson G; Archer T
    Psychopharmacology (Berl); 1989; 99(4):550-7. PubMed ID: 2594922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central and peripheral effects of lithium on amphetamine-induced hyperactivity in rats.
    Smith DF
    Pharmacol Biochem Behav; 1981 Apr; 14(4):439-42. PubMed ID: 6262841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of haloperidol on amphetamine- and methylphenidate-induced conditioned place preferences and locomotor activity.
    Mithani S; Martin-Iverson MT; Phillips AG; Fibiger HC
    Psychopharmacology (Berl); 1986; 90(2):247-52. PubMed ID: 3097706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice.
    Mines MA; Beurel E; Jope RS
    Eur J Pharmacol; 2013 Jan; 698(1-3):252-8. PubMed ID: 23099259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium attenuates drug-induced hyperactivity in rats.
    Cox C; Harrison-Read PE; Steinberg H; Tomkiewicz M
    Nature; 1971 Jul; 232(5309):336-8. PubMed ID: 5106744
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of treatment and withdrawal from chronic lithium in rats on stimulant-induced responses.
    Lerer B; Globus M; Brik E; Hamburger R; Belmaker RH
    Neuropsychobiology; 1984; 11(1):28-32. PubMed ID: 6738831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism by d-amphetamine of trimethyltin-induced hyperactivity evidence toward an animal model of hyperkinetic behavior.
    Swartzwelder HS; Holahan W; Myers RD
    Neuropharmacology; 1983 Sep; 22(9):1049-54. PubMed ID: 6685232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonizing effect of lithium on the development of dopamine supersensitivity in the tuberoinfundibular system.
    Tanimoto K; Maeda K; Chihara K
    Brain Res; 1982 Aug; 245(1):163-6. PubMed ID: 6811103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol and methylphenidate alter motor behavior and responses to conditioned fear of Carioca Low-conditioned Freezing rats.
    Lages YV; Maisonnette SS; Rosseti FP; Galvão BO; Landeira-Fernandez J
    Pharmacol Biochem Behav; 2021 Dec; 211():173296. PubMed ID: 34752797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haloperidol attenuates Methylphenidate and Modafinil induced behavioural sensitization and cognitive enhancement.
    Alam N; Choudhary K
    Metab Brain Dis; 2018 Jun; 33(3):893-906. PubMed ID: 29470766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute administration of lithium carbonate interferes with suckling in neonatal rats.
    McLaughlin CR; Cramer CP
    Pharmacol Biochem Behav; 1989 Feb; 32(2):453-8. PubMed ID: 2498909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium.
    Gould TD; O'Donnell KC; Picchini AM; Manji HK
    Neuropsychopharmacology; 2007 Jun; 32(6):1321-33. PubMed ID: 17151598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The paradoxical effect of central nervous system stimulants on hyperactivity: a paradox unexplained by the rate-dependent effect.
    Millard WJ; Standish LJ
    J Nerv Ment Dis; 1982 Aug; 170(8):499-501. PubMed ID: 6808087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperactive behavioural effects induced by intranigral infusion of a pyridinium metabolite of haloperidol in rats.
    Fang J
    Can J Physiol Pharmacol; 1996 Dec; 74(12):1359-61. PubMed ID: 9047047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium modulates the production of peripheral and cerebral cytokines in an animal model of mania induced by dextroamphetamine.
    Valvassori SS; Tonin PT; Varela RB; Carvalho AF; Mariot E; Amboni RT; Bianchini G; Andersen ML; Quevedo J
    Bipolar Disord; 2015 Aug; 17(5):507-17. PubMed ID: 25929806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
    Meller E; Friedman E
    Eur J Pharmacol; 1981 Nov; 76(1):25-9. PubMed ID: 7318921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperactivity: a lead-induced behavior disorder.
    Silbergeld EK; Goldberg AM
    Environ Health Perspect; 1974 May; 7():227-32. PubMed ID: 4857498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of amphetamine isomers to decrease hyperactivity in developing rats.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1982 Jul; 17(1):5-9. PubMed ID: 7122666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.